Imagine a world where an AI doctor is not just a futuristic concept but a reality, offering free primary care to patients around the clock. This bold vision is what Lotus Health, a startup with a mission, is bringing to life.
The inspiration for Lotus Health's founder, KJ Dhaliwal, stems from his childhood experiences as a medical translator for his parents, which made him acutely aware of the inefficiencies in the US healthcare system. With the advent of Large Language Models (LLMs), he saw an opportunity to revolutionize healthcare access.
Lotus Health AI was launched in May 2024, providing free primary care services in 50 languages, available 24/7. The company has just secured a significant $35 million in Series A funding, led by CRV and Kleiner Perkins, bringing its total funding to an impressive $41 million.
While people have been turning to AI for health advice, Lotus takes it a step further by offering actual medical care, including diagnoses, prescriptions, and specialist referrals. It's essentially building an AI doctor that operates like a traditional medical practice, complete with the necessary licenses, insurance, and patient record access.
The key innovation here is that the AI is trained to ask the same questions a doctor would, but with the added layer of human oversight. Board-certified doctors from top institutions review the AI's work to ensure accuracy and prevent any potential hallucinations that AI models are prone to.
Lotus's AI model, similar to OpenEvidence, synthesizes the latest evidence-based research with a patient's medical history and clinical answers to generate a personalized treatment plan. It's a powerful combination of AI advice and human expertise.
But here's where it gets controversial: outsourcing such a significant portion of medical decision-making to AI is a bold move, especially given the regulatory hurdles in healthcare. Lotus, however, believes that the telemedicine frameworks established during the pandemic, coupled with recent AI advancements, can help navigate these challenges.
Saar Gur, a general partner at CRV and an early investor in companies like DoorDash and Mercury, is convinced that Lotus has the potential to reimagine primary care. He acknowledges the challenges but believes that the rewards are worth the risk.
With a shortage of primary care doctors, Lotus claims it can see ten times more patients than a traditional practice, even with 15-minute visit limits. This is a game-changer for healthcare access.
Lotus is not alone in this endeavor; competitors like Lightspeed-backed Doctronic are also building AI doctors. However, Lotus's unique selling point, at least for now, is its commitment to offering its entire suite of care completely free.
Founder Dhaliwal hints at potential future business models, including sponsored content or subscriptions, but for now, the focus is on product development and patient attraction.
This is a bold, ambitious project that has the potential to transform healthcare as we know it. But it also raises important questions about the role of AI in medicine and the future of healthcare access. What do you think? Is Lotus Health onto something revolutionary, or is this a risky venture that could backfire? We'd love to hear your thoughts in the comments!
